2024-03-29T08:12:21Zhttps://www.tdx.cat/oai/requestoai:www.tdx.cat:10803/3966672017-09-01T16:56:37Zcom_10803_1col_10803_94
nam a 5i 4500
Neurociències
Neurociencias
Neurosciences
Biologia molecular
Biología molecular
Molecular biology
Àcid glutàmic
Acido glutámico
Glutamic acid
Novel regulation of AMPA receptor function by interacting protein CPT1C
[Barcelona] :
Universitat de Barcelona,
2016
Accés lliure
http://hdl.handle.net/10803/396667
cr |||||||||||
AAMMDDs2016 sp ||||fsm||||0|| 0 eng|c
Yefimenko Nosova, Natalia,
autor
1 recurs en línia (193 pàgines)
Tesi
Doctorat
Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental
2016
Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental
Tesis i dissertacions electròniques
Soto del Cerro, David,
supervisor acadèmic
Solsona Sancho, Carles,
supervisor acadèmic
TDX
AMPA receptors (AMPARs) are responsible for the 90% of synaptic transmission and are involved in plasticity, developmental and neurological processes. Their function depends on the proteins interacting with the AMPAR complex, which determine their specific gating and trafficking properties and hence their specific roles. In addition to well-known interacting proteins of AMPARs, recent studies have described the CPT1C as an associated partner in the outer core of the AMPAR complex in the hippocampus, cortex and cerebellum.
CPT1C is a neuron specific homologue of the carnitine acyltransferase family of enzymes, which are involved in fatty acid oxidation at the mitochondria. Contrary to the rest of the CPT1 family, CPT1C localizes at the endoplasmic reticulum and apparently is not related with the functions that other CPT1s carry out. To elucidate the physiological role of CPT1C isoform different studies have been performed, showing that CPT1C is involved in energy homeostasis, control of body weight and motor function as well as behavioral learning mechanisms. Of note, CPT1C KO animals display impairments in spatial learning along with immature dendritic spines. Despite all these studies with CPT1C, including its interaction with AMPARs, it is unknown the CPT1C physiological relevance and role, particularly in the regulation of the AMPAR function and its implication in neurological diseases.
In this thesis we have described a novel role of CPT1C in AMPA receptor function regulation. More specifically, the results show that glutamate-evoked currents of the recombinant GluA1 receptors are increased when CPT1C is present and this effect is specific of the CPT1 isoform CPT1C, since CPT1A does not share the same pattern. The ER location of CPT1C seems to be crucial to modulate AMPAR surface expression since mislocalization of CPT1C avoids its AMPAR modulation. Co-localization studies confirmed that GluA1-CPT1C interaction happens at ER level but not at the cell surface.
On the other hand, no changes in current density have been found in cells expressing GluA2 subunit along with CPT1C indicating AMPA subunit specificity. Additionally, electrophysiological experiments have determined that GluA1 channel properties are no altered, thus indicating that the increased current is probably due to a rise in AMPAR number at the cell surface. Indeed, this hypothesis is corroborated by the findings from the immunofluorescence experiments, where surface expression of GluA1 is increased in the presence of CPT1C in heterologous systems and cortical neurons. In agreement with a putative role of CPT1C in determining the AMPAR content at synapse level, we have demonstrated that synaptic transmission is altered in CPT1C KO neurons.
In parallel, we have studied the molecular mechanisms of CPT1C effect on AMPARs. We have shown that the palmitoylable cysteine 585 of the GluA1 subunit is crucial for the CPT1C enhancement of AMPA receptors trafficking by using immunofluorescence and electrophysiological techniques. However, the palmitoylation state of this residue does not determine AMPAR-CPT1C interaction. We have found evidences for a supposed depalmitoylation activity by CPT1C studying the role of the C-terminus of CPT1C, which contains the residue His469 with catalytic activity. Specifically we have found that CPT1C H469A mutant form does not alter GluA1 induced whole-cell currents as the wild type CPT1C does indicating that the C-terminal catalytic domain plays a crucial role in GluA1 modulation. This is supported by the fact that Palmostatin B – a newly described palmitoyl thioesterase inhibitor – decreases the CPT1C effect on GluA1 induced currents, most likely by inhibiting its PTE activity.
In summary, this thesis unravels a novel regulation of AMPA receptor function by the interacting protein CPT1C, which modulates AMPA receptor trafficking and this effect depends on the catalytic domain of CPT1C C-terminal acting on the cysteine 585 of GluA1 AMPAR subunit.
b
ES-BaCBU
cat
rda
ES-BaCBU
text
txt
rdacontent
informàtic
c
rdamedia
recurs en línia
cr
rdacarrier